Design, construction and testing of a low-cost automated 68Gallium-labeling synthesis unit
Am J Nucl Med Mol Imaging. 2016; 6(3): 176–184. The interest in 68Gallium labeled PET probes continues to increase around the world....
News & Updates
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.
- Jun 18, 2021
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without MoCo
European Journal of Nuclear Medicine and Molecular Imaging. 2018 Nov;45(12):2147-2154. Purpose: To compare the clinical performance of...
- Jun 18, 2021
18 F-Fluciclovine PET in Men With BCR PCa after Prostatectomy and planning for Salvage Radiation
Pract Radiat Oncol. Sep-Oct 2020;10(5):354-362 Purpose: Conventional imaging rarely localizes the site(s) of prostate cancer recurrence...
- Jun 18, 2021
18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810
Clin Cancer Res; 23(12); 3053-60. Purpose: Evaluate 18F-fluoroestradiol (FES) PET/CT as a biomarker of estrogen receptor (ER) occupancy...
- Jun 18, 2021
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease
Int J Radiat Oncol Biol Phys. 2018 Nov 15; 102(4): 1024–1028. Purpose: Response criteria of glioblastoma after chemoradiation do not...
- Jun 18, 2021
Clinical impact of PET/MR in treated colorectal cancer patients
European Journal of Nuclear Medicine and Molecular Imaging. 2019 Oct;46(11):2260-2269. Purpose: The primary aim of the present study was...
- Jun 18, 2021
Management implications of FDG PET/MR in untreated intrahepatic cholangiocarcinoma
European Journal of Nuclear Medicine and Molecular Imaging. 2020 Jul;47(8):1871-1884. Purpose: Intrahepatic cholangiocarcinoma (ICC) is...
- Jun 18, 2021
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases
Oncologist. 2020 Aug; 25(8): 652–660. Background We assessed the antitumor activity of cabozantinib, a potent multireceptor oral tyrosine...
- Jun 18, 2021
Improving staging of rectal cancer in the pelvis: the role of PET/MRI
European Journal of Nuclear Medicine and Molecular Imaging. 2021 Apr;48(4):1235-1245. Purpose The role of positron emission...
- Jun 18, 2021
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analys
European Journal of Nuclear Medicine and Molecular Imaging. volume 48, pages 1976–1986 (2021) Purpose To evaluate PET/MR lung nodule...
- Jun 18, 2021
Evaluation of the Diagnostic Performance of PET/MR for the Diagnosis of Liver Metastases
Invest Radiol. 2021 Mar 25. Objective: The aim of this study was to compare the performance of positron emission tomography...
- Jun 16, 2021
The Impact of PET with 18F-Fluciclovine on the Treatment of BCR of PCa: Results from the LOCATE Tria
J Urol. 2019 Feb; 201(2): 322–331. Purpose: The prospective, multicenter LOCATE (F Fluciclovine [FACBC] PET/CT in Patients with Rising...
- Jun 16, 2021
Multitargeted TKI produces discordant changes between 99mTc-MDP bone scans and other biomarkers
J Nucl Med. 2012 Nov; 53(11): 1670–1675. Purpose: One of the central unanswered questions in prostate cancer research is the significance...
- Jun 16, 2021
Prospective trial with optical molecular imaging for percutaneous interventions in hepatic lesions
Radiology. 2015 Mar;274(3):917-26. Purpose: To demonstrate the clinical translation of optical molecular imaging (OMI) for the...
- Jun 16, 2021
Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients
Gastroenterol Res Pract. 2016; 2016: 6184842. White light colonoscopy is the current gold standard for early detection and treatment of...
- Jun 15, 2021
Performance of fluciclovine PET/MR in the evaluation of osseous metastases from CRPC
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):105-114. Purpose: 18F-Fluciclovine is indicated for evaluation of suspected prostate cancer...
- Jun 15, 2021
Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma
Abdom Radiol (NY). 2021 Mar 27. Purpose: Radiation therapy (RT) is an effective treatment for unresectable cholangiocarcinoma (CC)....
- Jun 15, 2021
Baseline TLG measured with FDG PET/CT as a predictor of PFS in DLBCL
Am J Nucl Med Mol Imaging. 2013; 3(3): 272–281. This pilot study investigates the value of baseline total lesion glycolysis (TLG) in...
- Jun 15, 2021
A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC
Am J Nucl Med Mol Imaging. 2017; 7(2): 53–62. This prospective pilot study provides a dynamic whole body PET/MR image database, clinical...